US · Healthcare

DNAPrint Genomics Inc (DNAG)

Biotechnology

DNAPrint Genomics Inc (DNAG) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DNAG

P/E ratio

18.00

DNAPrint Genomics Inc (DNAG) — FAQ

What is DNAG's P/E ratio?

The price-to-earnings (P/E) ratio for DNAPrint Genomics Inc (DNAG) is 18.00 (data as of 2026-03-24).

Does DNAPrint Genomics Inc pay a dividend?

Dividend yield is not available in the current snapshot for DNAPrint Genomics Inc (DNAG). Check the MyAverix Finance app for the latest dividend data.

What sector is DNAPrint Genomics Inc in?

DNAPrint Genomics Inc (DNAG) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DNAG listed on?

DNAG is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)